Skip to Content
Merck
CN
  • High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains.

High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains.

Acta neuropathologica (2024-07-27)
Marius Schwabenland, Dilara Hasavci, Sibylle Frase, Katharina Wolf, Nikolaus Deigendesch, Joerg M Buescher, Kirsten D Mertz, Benjamin Ondruschka, Hermann Altmeppen, Jakob Matschke, Markus Glatzel, Stephan Frank, Robert Thimme, Juergen Beck, Jonas A Hosp, Thomas Blank, Bertram Bengsch, Marco Prinz
ABSTRACT

The underlying pathogenesis of neurological sequelae in post-COVID-19 patients remains unclear. Here, we used multidimensional spatial immune phenotyping and machine learning methods on brains from initial COVID-19 survivors to identify the biological correlate associated with previous SARS-CoV-2 challenge. Compared to healthy controls, individuals with post-COVID-19 revealed a high percentage of TMEM119+P2RY12+CD68+Iba1+HLA-DR+CD11c+SCAMP2+ microglia assembled in prototypical cellular nodules. In contrast to acute SARS-CoV-2 cases, the frequency of CD8+ parenchymal T cells was reduced, suggesting an immune shift toward innate immune activation that may contribute to neurological alterations in post-COVID-19 patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-APP A4 Antibody, a.a. 66-81 of APP {NT}, clone 22C11, clone 22C11, Chemicon®, from mouse